Skip to main content
. 2005 Feb 10;7(2):64–69. doi: 10.1186/bcr1007

Figure 6.

Figure 6

Phase III adjuvant trial comparing standard versus accelerated 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) regimen in early breast cancer patients. Results from the Gruppo Oncologico del Nord-Ovest group MIG1 study. G-CSF, granulocyte colony-stimulating factor. Adapted from Venturini and coworkers [22].